These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30505727)

  • 1. Feasibility of using a novel non-invasive ambulatory tibial nerve stimulation device for the home-based treatment of overactive bladder symptoms.
    Seth JH; Gonzales G; Haslam C; Pakzad M; Vashisht A; Sahai A; Knowles C; Tucker A; Panicker J
    Transl Androl Urol; 2018 Dec; 7(6):912-919. PubMed ID: 30505727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS).
    Martin-Garcia M; Crampton J
    Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of a Transcutaneous Tibial Nerve Stimulation Device Use in Overactive Bladder Patients: A Pilot Study From a Single Tertiary Care Center.
    Li X; Li X; Zhou Z; Zhao H; Liao L
    Front Neurol; 2022; 13():872200. PubMed ID: 35528738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of tibial nerve stimulation using a wearable device for overactive bladder.
    Liao L; Li X; Chong T; Chen Q; Xu Z; Huang B; Chen M; Li H; Wei Z; Shao Y; Lu J; Pang R; Li X; Wang Y
    BJU Int; 2024 Jun; 133(6):760-769. PubMed ID: 38468422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review.
    Booth J; Connelly L; Dickson S; Duncan F; Lawrence M
    Neurourol Urodyn; 2018 Feb; 37(2):528-541. PubMed ID: 28731583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcutaneous tibial nerve electrical stimulation versus vaginal electrical stimulation in women with overactive bladder syndrome: Is there a role for short-term interventions?
    Nunes JMO; Gregório EP; Moreira ECH; Hazime FA; Averbeck MA; de Almeida SHM
    Neurourol Urodyn; 2023 Jun; 42(5):1101-1110. PubMed ID: 37042223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and acceptability of transcutaneous tibial nerve stimulation for the treatment of bladder storage symptoms among people with multiple sclerosis.
    Al Dandan HB; Galvin R; Robinson K; McClurg D; Coote S
    Pilot Feasibility Stud; 2022 Jul; 8(1):161. PubMed ID: 35908067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New TENSI+ Device for Transcutaneous Posterior Tibial Nerve Stimulation: A Prospective, Multicentre, Post-market Clinical Study.
    Cornu JN; Donon L; Thullier C; Meyer F; Klap J; Campagne-Loiseau S; Mariadassou A; Peyronnet B
    Eur Urol Focus; 2024 May; ():. PubMed ID: 38816338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Transcutaneous and Percutaneous Tibial Nerve Stimulation in Bosnian Female Patients with an Idiopathic Overactive Urinary Bladder.
    Zonić-Imamović M; Sinanović O; Imamović M; Muftić M; Janković S; Bazardžanović M
    Acta Med Acad; 2021 Aug; 50(2):235-243. PubMed ID: 34847676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial.
    Sonmez R; Yildiz N; Alkan H
    Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of transcutaneous tibial nerve stimulation (TTNS) protocols for women with refractory overactive bladder (OAB): A prospective randomised trial.
    Alkis O; Sevim M; Güven Kartal İ; Baser A; İbrahim İvelik H; Aras B
    Int J Clin Pract; 2021 Sep; 75(9):e14342. PubMed ID: 33966335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome.
    Ramírez-García I; Kauffmann S; Blanco-Ratto L; Carralero-Martínez A; Sánchez E
    Neurourol Urodyn; 2021 Jan; 40(1):295-302. PubMed ID: 33118624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report.
    Patidar N; Mittal V; Kumar M; Sureka SK; Arora S; Ansari MS
    J Pediatr Urol; 2015 Dec; 11(6):351.e1-6. PubMed ID: 26279104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, controlled trial of transcutaneous tibial nerve stimulation to treat overactive bladder and neurogenic bladder patients.
    Welk B; McKibbon M
    Can Urol Assoc J; 2020 Jul; 14(7):E297-E303. PubMed ID: 32017693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder.
    Salatzki J; Liechti MD; Spanudakis E; Gonzales G; Baldwin J; Haslam C; Pakzad M; Panicker JN
    BJU Int; 2019 May; 123(5A):E20-E28. PubMed ID: 30552801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the effects of transcutaneous tibial nerve stimulation or pelvic floor muscle training on sexual dysfunction in female multiple sclerosis patients reporting overactive bladder.
    Polat Dunya C; Tülek Z; Kürtüncü M; Gündüz T; Panicker JN; Eraksoy M
    Neurourol Urodyn; 2021 Aug; 40(6):1661-1669. PubMed ID: 34174117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous tibial nerve stimulation versus sham efficacy in the treatment of refractory overactive bladder: outcomes following a shortened 6-week protocol, a prospective randomized controlled trial.
    Lashin AM; Eltabey NA; Wadie BS
    Int Urol Nephrol; 2021 Dec; 53(12):2459-2467. PubMed ID: 34601705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home-based transcutaneous tibial nerve stimulation for overactive bladder syndrome: a randomized, controlled study.
    Cava R; Orlin Y
    Int Urol Nephrol; 2022 Aug; 54(8):1825-1835. PubMed ID: 35622269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.
    Ghijselings L; Renson C; Van de Walle J; Everaert K; Spinoit AF
    Trials; 2021 Apr; 22(1):247. PubMed ID: 33810804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of transcutaneous tibial nerve stimulation at two different thresholds for overactive bladder symptoms in older women: a randomized controlled clinical trial.
    Teixeira Alve A; Azevedo Garcia P; Henriques Jácomo R; Batista de Sousa J; Borges Gullo Ramos Pereira L; Barbaresco Gomide Mateus L; Gomes de Oliveira Karnikoskwi M
    Maturitas; 2020 May; 135():40-46. PubMed ID: 32252963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.